Showing 2 posts of 2 posts found.


Catalyst’s lead candidate Firdapse falls short in Congenital Myasthenic Syndromes

October 31, 2019
Research and Development Catalyst Pharmaceuticals, FDA, firdapse, pharma, trial failure

Catalyst Pharmaceuticals has made it known that its lead product Firdapse (Amifampridine Phosphate) fell short of its primary endpoint in …


Catalyst Pharma sues FDA after agency approves Jacobus’ LEMS drug

June 13, 2019
Business Services, Manufacturing and Production FDA, Jacobus, catalyst, firdapse, pharma, ruzurgi

Florida firm Catalyst Pharmaceuticals is suing the FDA after the agency approved a rival’s drug. The lawsuit alleges the approval …

Latest content